TABLE 1.
Summary of NCI-60 cancer cell panel screening results.
| Panel/Cell line | GI50 | LC50 |
|---|---|---|
| Leukemia | ||
| CCRF-CEM | 1.05E-06 | > 1.00e-4 |
| HL-60(TB) | 1.93E-06 | > 1.00e-4 |
| K-562 | 2.36E-06 | > 1.00e-4 |
| MOLT-4 | 2.71E-06 | > 1.00e-4 |
| SR | 3.50E-08 | > 1.00e-4 |
| Non-Small Cell Liung Cancer | ||
| A549/ATCC | 1.64E-05 | > 1.00e-4 |
| EKVX | 1.31E-05 | 6.05E-05 |
| HOP-62 | 3.10E-06 | 3.00E-05 |
| HOP-92 | 2.38E-06 | 1.44E-05 |
| NCI-H226 | 3.21E-06 | > 1.00e-4 |
| NCI-H23 | 3.31E-06 | > 1.00e-4 |
| NCI-H322M | 1.36E-05 | 6.24E-05 |
| NCI-H460 | 3.74E-06 | > 1.00e-4 |
| *NCI-H522 | 1.72E-06 | 6.43E-06 |
| Colon Cancer | ||
| *COLO 205 | 1.24E-06 | 6.69E-06 |
| *HCC-2998 | 2.12E-06 | 8.70E-06 |
| *HCT-116 | 1.97E-06 | 7.65E-06 |
| HCT-15 | 1.93E-06 | n/a |
| HT29 | 2.33E-06 | > 1.00e-4 |
| KM12 | 3.51E-06 | 5.00E-05 |
| SW-620 | 1.60E-06 | > 1.00e-4 |
| CNS Cancer | ||
| SF-268 | 2.32E-06 | > 1.00e-4 |
| SF-295 | 1.54E-05 | 5.74E-05 |
| SF-539 | 2.42E-06 | > 1.00e-4 |
| SNB-19 | 1.06E-05 | > 1.00e-4 |
| SNB-75 | 2.67E-05 | > 1.00e-4 |
| U251 | 1.16E-05 | 5.51E-05 |
| Prostate Cancer | ||
| PC-3 | 2.52E-06 | 7.76E-05 |
| DU-145 | 1.39E-06 | n/a |
| Panel/Cell line | GI50 | LC50 |
|---|---|---|
| Melanoma | ||
| LOX IMVI | 9.76E-07 | > 1.00e-4 |
| MALME-3M | 2.31E-06 | > 1.00e-4 |
| *M14 | 1.90E-06 | 8.80E-06 |
| *MDA-MD-435 | 1.92E-06 | 9.17E-06 |
| SK-MEL-2 | 1.30E-05 | 5.53E-05 |
| *SK-MEL-28 | 1.83E-06 | 7.17E-06 |
| SK-MEL-5 | 3.54E-06 | 3.78E-05 |
| UACC-357 | 2.98E-06 | 3.14E-05 |
| *UACC-62 | 1.75E-06 | 7.96E-06 |
| Ovarian Cancer | ||
| OVCAR-3 | 1.04E-06 | n/a |
| OVCAR-4 | 3.51E-06 | 4.78E-05 |
| OVCAR-5 | 4.55E-06 | 9.40E-05 |
| OVCAR-8 | 3.36E-06 | > 1.00e-4 |
| NCI/ADR-RES | 3.01E-06 | > 1.00e-4 |
| SK-OV-3 | 1.66E-05 | 5.59E-05 |
| Renal Cancer | ||
| *786-O | 1.79E-06 | 6.55E-06 |
| A498 | 1.55E-05 | 5.44E-05 |
| ACHN | 1.46E-06 | 1.46E-05 |
| CAKI-1 | 1.41E-06 | 5.32E-05 |
| *RXF 393 | 1.73E-06 | 6.17E-06 |
| SN12C | 1.93E-06 | n/a |
| *TK-10 | 1.49E-06 | 5.79E-06 |
| *UO-31 | 1.57E-06 | 6.33E-06 |
| Breast Cancer | ||
| MCF7 | 1.17E-06 | > 1.00e-4 |
| HS 578T | 3.78E-06 | > 1.00e-4 |
| BT-549 | 2.38E-06 | 2.68E-05 |
| T-47D | 1.27E-06 | > 1.00e-4 |
| MDA-MB-468 | 1.61E-06 | > 1.00e-4 |
50/60 (83.3%) GI50 < 4.55 mM; 12/60 (20%) LC50 < 10 mM.